Mariner’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.69M Buy
100,780
+28,012
+38% +$469K ﹤0.01% 1454
2025
Q1
$1.12M Buy
72,768
+13,412
+23% +$206K ﹤0.01% 1610
2024
Q4
$1.31M Buy
59,356
+5,689
+11% +$125K ﹤0.01% 1464
2024
Q3
$964K Buy
53,667
+6,870
+15% +$123K ﹤0.01% 1634
2024
Q2
$760K Sell
46,797
-1,105
-2% -$18K ﹤0.01% 1710
2024
Q1
$676K Buy
47,902
+6,456
+16% +$91.1K ﹤0.01% 1802
2023
Q4
$433K Buy
41,446
+7,223
+21% +$75.4K ﹤0.01% 2046
2023
Q3
$349K Buy
34,223
+12,274
+56% +$125K ﹤0.01% 2022
2023
Q2
$165K Sell
21,949
-22,532
-51% -$170K ﹤0.01% 2524
2023
Q1
$394K Buy
44,481
+10,996
+33% +$97.4K ﹤0.01% 1856
2022
Q4
$306K Buy
33,485
+3,103
+10% +$28.4K ﹤0.01% 2014
2022
Q3
$245K Buy
+30,382
New +$245K ﹤0.01% 1914
2020
Q4
Sell
-58,282
Closed -$525K 807
2020
Q3
$525K Sell
58,282
-4,048
-6% -$36.5K ﹤0.01% 606
2020
Q2
$769K Sell
62,330
-2,692
-4% -$33.2K 0.01% 527
2020
Q1
$586K Buy
65,022
+5,431
+9% +$48.9K 0.01% 555
2019
Q4
$584K Buy
59,591
+783
+1% +$7.67K 0.01% 587
2019
Q3
$405K Buy
58,808
+336
+0.6% +$2.31K ﹤0.01% 619
2019
Q2
$540K Buy
58,472
+8,353
+17% +$77.1K 0.01% 700
2019
Q1
$786K Buy
50,119
+69
+0.1% +$1.08K 0.01% 548
2018
Q4
$772K Buy
50,050
+1,730
+4% +$26.7K 0.01% 487
2018
Q3
$1.04M Sell
48,320
-1,368
-3% -$29.5K 0.03% 403
2018
Q2
$1.21M Buy
+49,688
New +$1.21M 0.03% 366
2017
Q3
Sell
-9,500
Closed -$316K 522
2017
Q2
$316K Hold
9,500
0.01% 403
2017
Q1
$305K Sell
9,500
-68
-0.7% -$2.18K 0.01% 457
2016
Q4
$347K Sell
9,568
-322
-3% -$11.7K 0.02% 421
2016
Q3
$455K Sell
9,890
-2,439
-20% -$112K 0.02% 384
2016
Q2
$619K Buy
12,329
+7,902
+178% +$397K 0.03% 300
2016
Q1
$237K Buy
+4,427
New +$237K 0.01% 441
2015
Q4
Sell
-12,074
Closed -$682K 552
2015
Q3
$682K Buy
12,074
+600
+5% +$33.9K 0.03% 294
2015
Q2
$678K Buy
+11,474
New +$678K 0.03% 302